George Soros’s Zimmer Biomet ZBH Stock Holding History

George Soros’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-131,840	Closed	-$14M	–	263
2018 Q1	$14M	Sell	131,840 -2,575	-2%	-$299K	0.23%	101
2017 Q4	$15.7M	Buy	134,415 +70,040	+109%	+$7.92M	0.36%	60
2017 Q3	$7.32M	Buy	+64,375	New	+$7.43M	0.17%	87
2016 Q1	–	Sell	-4,841	Closed	-$482K	–	326
2015 Q4	$482K	Buy	+4,841	New	+$474K	0.01%	187

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

George Soros's ZBH Position: Q2 2018 in Review

George Soros sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 131,840 shares — an estimated $14M sold.

George Soros first reported a position in ZBH in Q4 2015 and held it in 4 quarters. The position peaked at $15.7M in Q4 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

George Soros reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
George Soros sold 131,840 Zimmer Biomet shares in Q2 2018, an estimated $14M.
George Soros first reported a position in Zimmer Biomet in Q4 2015 and held it in 4 quarters.
George Soros's Zimmer Biomet position peaked at $15.7M in Q4 2017.
870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Soros Fund Management's 13F filing for Q2 2018, filed 14 Aug 2018.